{"id":"https://openalex.org/W2994902810","doi":"https://doi.org/10.14412/2074-2711-2019-4-125-129","title":"New possibilities for the therapy of secondary progressive multiple sclerosis","display_name":"New possibilities for the therapy of secondary progressive multiple sclerosis","publication_year":2019,"publication_date":"2019-12-08","ids":{"openalex":"https://openalex.org/W2994902810","doi":"https://doi.org/10.14412/2074-2711-2019-4-125-129","mag":"2994902810"},"language":"en","primary_location":{"id":"doi:10.14412/2074-2711-2019-4-125-129","doi":"https://doi.org/10.14412/2074-2711-2019-4-125-129","is_oa":true,"landing_page_url":"https://doi.org/10.14412/2074-2711-2019-4-125-129","pdf_url":"https://nnp.ima-press.net/nnp/article/download/1221/975","source":{"id":"https://openalex.org/S4210231845","display_name":"Neurology neuropsychiatry Psychosomatics","issn_l":"2074-2711","issn":["2074-2711","2310-1342"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310312717","host_organization_name":"IMA-PRESS LLC","host_organization_lineage":["https://openalex.org/P4310312717"],"host_organization_lineage_names":["IMA-PRESS LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology, Neuropsychiatry, Psychosomatics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://nnp.ima-press.net/nnp/article/download/1221/975","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090219209","display_name":"Andrey M. Petrov","orcid":"https://orcid.org/0000-0001-9648-5492","observed_orcids":["https://orcid.org/0000-0001-9648-5492"]},"institutions":[{"id":"https://openalex.org/I1313323035","display_name":"Russian Academy of Sciences","ror":"https://ror.org/05qrfxd25","country_code":"RU","type":"government","lineage":["https://openalex.org/I1313323035"]},{"id":"https://openalex.org/I4210105947","display_name":"Institute of the Human Brain","ror":"https://ror.org/01ska0903","country_code":"RU","type":"facility","lineage":["https://openalex.org/I1313323035","https://openalex.org/I4210105947","https://openalex.org/I4210115279"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A. M. Petrov","raw_affiliation_strings":["N.P. Bekhtereva Institute of the Human Brain, Russian Academy of Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"N.P. Bekhtereva Institute of the Human Brain, Russian Academy of Sciences","institution_ids":["https://openalex.org/I1313323035","https://openalex.org/I4210105947"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011682394","display_name":"\u0415. \u0412. \u0418\u0432\u0430\u0448\u043a\u043e\u0432\u0430","orcid":"https://orcid.org/0000-0002-0201-0136","observed_orcids":["https://orcid.org/0000-0002-0201-0136"]},"institutions":[{"id":"https://openalex.org/I1313323035","display_name":"Russian Academy of Sciences","ror":"https://ror.org/05qrfxd25","country_code":"RU","type":"government","lineage":["https://openalex.org/I1313323035"]},{"id":"https://openalex.org/I4210105947","display_name":"Institute of the Human Brain","ror":"https://ror.org/01ska0903","country_code":"RU","type":"facility","lineage":["https://openalex.org/I1313323035","https://openalex.org/I4210105947","https://openalex.org/I4210115279"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"E. V. Ivashkova","raw_affiliation_strings":["N.P. Bekhtereva Institute of the Human Brain, Russian Academy of Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"N.P. Bekhtereva Institute of the Human Brain, Russian Academy of Sciences","institution_ids":["https://openalex.org/I1313323035","https://openalex.org/I4210105947"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5106403917","display_name":"I D Stolyarov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1313323035","display_name":"Russian Academy of Sciences","ror":"https://ror.org/05qrfxd25","country_code":"RU","type":"government","lineage":["https://openalex.org/I1313323035"]},{"id":"https://openalex.org/I4210105947","display_name":"Institute of the Human Brain","ror":"https://ror.org/01ska0903","country_code":"RU","type":"facility","lineage":["https://openalex.org/I1313323035","https://openalex.org/I4210105947","https://openalex.org/I4210115279"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"I. D. Stolyarov","raw_affiliation_strings":["N.P. Bekhtereva Institute of the Human Brain, Russian Academy of Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"N.P. Bekhtereva Institute of the Human Brain, Russian Academy of Sciences","institution_ids":["https://openalex.org/I1313323035","https://openalex.org/I4210105947"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4982,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.62177881,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"11","issue":"4","first_page":"125","last_page":"129"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/secondary-progressive-multiple-sclerosis","display_name":"secondary progressive multiple sclerosis","score":0.9860000014305115},{"id":"https://openalex.org/keywords/siponimod","display_name":"siponimod","score":1.0},{"id":"https://openalex.org/keywords/sphingosine-1-phosphate-receptor-modulator","display_name":"sphingosine-1-phosphate receptor modulator","score":0.972000002861023},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.7310000061988831},{"id":"https://openalex.org/keywords/disability-progression","display_name":"disability progression","score":0.9169999957084656},{"id":"https://openalex.org/keywords/expand-trial","display_name":"EXPAND trial","score":0.9649999737739563},{"id":"https://openalex.org/keywords/cognitive-function","display_name":"cognitive function","score":0.6150000095367432},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7239999771118164},{"id":"https://openalex.org/keywords/liver-failure","display_name":"liver failure","score":0.8360000252723694},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.5529999732971191},{"id":"https://openalex.org/keywords/upper-respiratory-tract-infection","display_name":"upper respiratory tract infection","score":0.6919999718666077},{"id":"https://openalex.org/keywords/cancer-risk","display_name":"cancer risk","score":0.5989999771118164}],"concepts":[{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7340831756591797},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7118596434593201},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5994883179664612},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5374219417572021},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5366731286048889},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.5246620178222656},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.47496554255485535},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.1911008358001709},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.12115281820297241},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.14412/2074-2711-2019-4-125-129","doi":"https://doi.org/10.14412/2074-2711-2019-4-125-129","is_oa":true,"landing_page_url":"https://doi.org/10.14412/2074-2711-2019-4-125-129","pdf_url":"https://nnp.ima-press.net/nnp/article/download/1221/975","source":{"id":"https://openalex.org/S4210231845","display_name":"Neurology neuropsychiatry Psychosomatics","issn_l":"2074-2711","issn":["2074-2711","2310-1342"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310312717","host_organization_name":"IMA-PRESS LLC","host_organization_lineage":["https://openalex.org/P4310312717"],"host_organization_lineage_names":["IMA-PRESS LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology, Neuropsychiatry, Psychosomatics","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:8c613ea51d0f41bba89ae1661e68182a","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/8c613ea51d0f41bba89ae1661e68182a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"\u041d\u0435\u0432\u0440\u043e\u043b\u043e\u0433\u0438\u044f, \u043d\u0435\u0439\u0440\u043e\u043f\u0441\u0438\u0445\u0438\u0430\u0442\u0440\u0438\u044f, \u043f\u0441\u0438\u0445\u043e\u0441\u043e\u043c\u0430\u0442\u0438\u043a\u0430, Vol 11, Iss 4, Pp 125-129 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.14412/2074-2711-2019-4-125-129","doi":"https://doi.org/10.14412/2074-2711-2019-4-125-129","is_oa":true,"landing_page_url":"https://doi.org/10.14412/2074-2711-2019-4-125-129","pdf_url":"https://nnp.ima-press.net/nnp/article/download/1221/975","source":{"id":"https://openalex.org/S4210231845","display_name":"Neurology neuropsychiatry Psychosomatics","issn_l":"2074-2711","issn":["2074-2711","2310-1342"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310312717","host_organization_name":"IMA-PRESS LLC","host_organization_lineage":["https://openalex.org/P4310312717"],"host_organization_lineage_names":["IMA-PRESS LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology, Neuropsychiatry, Psychosomatics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2994902810.pdf","grobid_xml":"https://content.openalex.org/works/W2994902810.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W1479686875","https://openalex.org/W1493585689","https://openalex.org/W1494056289","https://openalex.org/W1763205699","https://openalex.org/W2013234597","https://openalex.org/W2066360939","https://openalex.org/W2077880067","https://openalex.org/W2092814331","https://openalex.org/W2100830657","https://openalex.org/W2136325849","https://openalex.org/W2159963451","https://openalex.org/W2160872052","https://openalex.org/W2162978315","https://openalex.org/W2172431827","https://openalex.org/W2280843498","https://openalex.org/W2517566610","https://openalex.org/W2549644306","https://openalex.org/W2575139667","https://openalex.org/W2596982404","https://openalex.org/W2600369824","https://openalex.org/W2619071466","https://openalex.org/W2767151013","https://openalex.org/W2790816436","https://openalex.org/W2802785428","https://openalex.org/W2902015118","https://openalex.org/W2908132483","https://openalex.org/W3111909225"],"related_works":["https://openalex.org/W3196909241","https://openalex.org/W4281916721","https://openalex.org/W4281386121","https://openalex.org/W7015571891","https://openalex.org/W2999381801","https://openalex.org/W3095050113","https://openalex.org/W4281650051","https://openalex.org/W2777830529","https://openalex.org/W2902015118","https://openalex.org/W3006258255"],"abstract_inverted_index":{"Patients":[0],"with":[1,57,133,155,175,212],"multiple":[2],"sclerosis":[3],"(MS)":[4],"are":[5],"at":[6],"high":[7],"risk":[8,145,197,206],"for":[9,26,198],"transition":[10],"to":[11,43,112],"secondary":[12],"progressive":[13],"MS":[14,75],"(SPMS).":[15],"To":[16],"date,":[17],"there":[18],"has":[19,40,215],"not":[20,193],"been":[21,41],"a":[22,30,195,216],"sufficiently":[23],"effective":[24,46],"therapy":[25],"SPMS.":[27],"Siponimod":[28,191],"is":[29],"selective":[31],"sphingosine-1-phosphate":[32],"types":[33],"1":[34],"and":[35,88,118,123,179,214],"5":[36],"receptor":[37],"modulator":[38],"that":[39],"shown":[42],"be":[44],"more":[45,185],"than":[47],"placebo":[48],"in":[49,55,59,187,210],"slowing":[50],"the":[51,60,72,77,80,86,96,99,105,110,139,144,166,188,205],"progression":[52,116,209],"of":[53,74,79,82,84,90,98,107,146,152,162,168,207],"disability":[54,115,208],"patients":[56,132,140,211],"SPMS":[58,134,213],"international":[61],"phase":[62],"III":[63],"(EXPAND)":[64],"clinical":[65,122],"trial.":[66],"This":[67],"review":[68],"analyzes":[69],"data":[70,129],"on":[71,130],"pathophysiology":[73],"progression,":[76],"features":[78],"mechanism":[81],"action":[83],"siponimod,":[85,143],"efficiency":[87],"safety":[89,218],"its":[91],"use,":[92],"including":[93],"those":[94,156],"by":[95,109,149],"results":[97],"EXPAND":[100],"study.":[101],"The":[102,126,160,202],"latter":[103],"studied":[104],"efficacy":[106],"siponimod":[108,163,189],"time":[111],"3-month":[113],"confirmed":[114],"(3M-CDP)":[117],"also":[119],"assessed":[120],"other":[121],"radiological":[124],"parameters.":[125],"analysis":[127],"included":[128],"1,651":[131],"from":[135],"31":[136],"countries.":[137],"In":[138],"who":[141,157],"received":[142],"3M-CDP":[147],"decreased":[148],"an":[150],"average":[151],"21%":[153],"compared":[154],"took":[158],"placebo.":[159],"administration":[161],"positively":[164],"affected":[165],"speed":[167],"cognitive":[169],"processes.":[170],"Mild":[171],"adverse":[172],"events":[173],"associated":[174],"liver":[176],"failure,":[177],"hypertension,":[178],"upper":[180],"respiratory":[181],"tract":[182],"infections":[183],"were":[184],"common":[186],"group.":[190],"did":[192],"pose":[194],"higher":[196],"developing":[199],"malignant":[200],"neoplasms.":[201],"drug":[203],"reduces":[204],"favorable":[217],"profile.":[219]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2019-12-26T00:00:00"}
